Table 4.
Adverse events during the study
|
Groups |
||||
| 1 (n = 60) | 2 (n = 57) | 3 (n = 60) | 4 (n = 63) | |
| Insomnia | 3 | 4 | 4 | 0 |
| Dizziness | 1 | 1 | 0 | 0 |
| Dry mouth | 1 | 2 | 1 | 0 |
| Nausea | 1 | 1 | 0 | 1 |
| Skin rash | 0 | 1 | 0 | 1 |
Adverse events during the study
|
Groups |
||||
| 1 (n = 60) | 2 (n = 57) | 3 (n = 60) | 4 (n = 63) | |
| Insomnia | 3 | 4 | 4 | 0 |
| Dizziness | 1 | 1 | 0 | 0 |
| Dry mouth | 1 | 2 | 1 | 0 |
| Nausea | 1 | 1 | 0 | 1 |
| Skin rash | 0 | 1 | 0 | 1 |